Related Experiment Video
Updated: Mar 29, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Pathogenic FBN1 variants in familial thoracic aortic aneurysms and dissections
E S Regalado1, D C Guo1, R L P Santos-Cortez2
1Division of Medical Genetics, Department of Internal Medicine, University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Abstract:
Marfan syndrome (MFS) due to mutations in FBN1 is a known cause of thoracic aortic aneurysms and acute aortic dissections (TAAD) associated with pleiotropic manifestations. Genetic predisposition to TAAD can also be inherited in families in the absence of syndromic features, termed familial TAAD (FTAAD), and several causative genes have been identified to date. FBN1 mutations can also be identified in FTAAD families, but the frequency of these mutations has not been established. We performed exome sequencing of 183 FTAAD families and identified pathogenic FBN1 variants in five (2.7%) of these families. We also identified eight additional FBN1 rare variants that could not be unequivocally classified as disease-causing in six families. FBN1 sequencing should be considered in individuals with FTAAD even without significant systemic features of MFS.
Insights
Mutations in the FBN1 gene are linked to Marfan syndrome (MFS) and familial thoracic aortic aneurysms and dissections (FTAAD). This study found FBN1 variants in 2.7% of FTAAD families, suggesting FBN1 testing is valuable for FTAAD diagnosis.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Molecular Biology
Background:
- Marfan syndrome (MFS), caused by FBN1 mutations, leads to thoracic aortic aneurysms and dissections (TAAD).
- Familial TAAD (FTAAD) is an inherited form of TAAD without syndromic features, with several causative genes identified.
- The frequency of FBN1 mutations in FTAAD families is not well-established.
Purpose of the Study:
- To determine the frequency of pathogenic FBN1 variants in families with familial thoracic aortic aneurysms and dissections (FTAAD).
- To evaluate the role of FBN1 mutations in the genetic etiology of FTAAD.
Main Methods:
- Exome sequencing was performed on 183 families diagnosed with FTAAD.
- Pathogenic and rare FBN1 variants were identified and analyzed.
Main Results:
- Pathogenic FBN1 variants were identified in 5 out of 183 (2.7%) FTAAD families.
- An additional 8 rare FBN1 variants of uncertain significance were found in 6 families.
Conclusions:
- FBN1 mutations are a cause of familial thoracic aortic aneurysms and dissections (FTAAD).
- FBN1 gene sequencing should be considered in the diagnostic workup of individuals with FTAAD, even in the absence of typical Marfan syndrome features.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aortic Regurgitation I: Introduction
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

